IP Library › Patent Application 18676285
Patent Application
App. No. 18/676,285

Anti-Bed Bug Monoclonal Antibodies and Methods of Making and Uses Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/676,285
Abstract

The present disclosure provides anti-bed bug monoclonal antibodies and antigen-binding fragments thereof as well as compositions and kits comprising the same. The present disclosure also provides methods of making monoclonal antibodies and antigen-binding fragments thereof and methods of using the same to detect bed bugs.

Claims (29)

1 . An antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2] or PTA-122645 [BB7], or an antigen-binding fragment thereof.

2 . (canceled)

3 . A monoclonal antibody or an antigen-binding fragment thereof comprising the heavy and light chain complementarity determining regions of the antibody of claim 1 .

4 . The antibody or antigen-binding fragment of claim 3 , comprising the heavy and light chain variable regions of the antibody of claim 1 .

5 . The antibody or antigen-binding fragment of claim 4 , comprising the heavy and light chains of the antibody of claim 1 .

6 . The antibody or antigen-binding fragment of claim 1 , wherein the antibody or antigen-binding fragment is capable of binding to a bed bug antigen in a lysate of whole bed bugs or an extract of collection paper comprising bed bug waste material.

7 . A mutant of the antibody or antigen-binding fragment of claim 1 , wherein the mutant is capable of binding to a bed bug antigen in a lysate of whole bed bugs or an extract of collection paper comprising bed bug waste material.

8 . (canceled)

9 . A conjugated monoclonal antibody or conjugated antigen-binding fragment, comprising the antibody or antigen-binding fragment of claim 1 and a detection agent.

10 . The conjugated antibody or conjugated antigen-binding fragment of claim 9 , wherein the detection agent is colloidal gold.

11 . The conjugated antibody or conjugated antigen-binding fragment of claim 9 , comprising the antibody produced by the hybridoma deposited at the ATCC under Accession Number PTA-122644 [BB2], or an antigen binding fragment thereof.

12 . The conjugated antibody or conjugated antigen-binding fragment of claim 9 , comprising the antibody produced by the hybridoma deposited at the ATCC under Accession Number PTA-122645 [BB7], or an antigen binding fragment thereof.

13 . A composition comprising the antibody or antigen-binding fragment of claim 1 .

14 . A composition comprising:

(a) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], and

(b) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], or the conjugated antibody of claim 12 .

15 . A composition comprising:

(a) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], and

(b) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], or the conjugated antibody of claim 11 .

16 . A kit comprising the antibody or antigen-binding fragment of claim 1 .

17 . A hybridoma capable of producing an antibody, wherein the hybridoma is deposited at the ATCC under Accession Number PTA-122644 [BB2] or PTA-122645 [BB7].

18 . (canceled)

19 . An isolated cell producing the antibody or antigen-binding fragment of claim 1 .

20 . A method of making the antibody or antigen-binding fragment of claim 1 , comprising (a) culturing a cell that produces the antibody or antigen-binding fragment, and (b) isolating the antibody or antigen-binding fragment from the cultured cell.

21 . A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with the antibody or antigen-binding fragment of claim 1 , and detecting binding of the bed bug antigen to the antibody or antigen-binding fragment.

22 . (canceled)

23 . A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], the conjugated antibody of claim 12 .

24 . A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], and the conjugated antibody of claim 11 .

25 - 27 . (canceled)